| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000039545 |
| Receipt No. | R000045002 |
| Scientific Title | A retrospective study on the effect of resection, laser treatment, and risk factors for malignant transformation and postoperative recurrence in vocal fold leukoplakia |
| Date of disclosure of the study information | 2020/02/20 |
| Last modified on | 2020/02/20 (Ver. 1) |
| Basic information | ||
| Public title | A retrospective study on the effect of resection, laser treatment, and risk factors for malignant transformation and postoperative recurrence in vocal fold leukoplakia | |
| Acronym | A retrospective study on the effect of resection, laser treatment, and risk factors for malignant transformation and postoperative recurrence in vocal fold leukoplakia | |
| Scientific Title | A retrospective study on the effect of resection, laser treatment, and risk factors for malignant transformation and postoperative recurrence in vocal fold leukoplakia | |
| Scientific Title:Acronym | A retrospective study on the effect of resection, laser treatment, and risk factors for malignant transformation and postoperative recurrence in vocal fold leukoplakia | |
| Region |
|
|
| Condition | ||
| Condition | Vocal fold leukoplakia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We compare the clinical characteristics of patients with vocal fold leukoplakia who have visited our hospital with those who have not recurred and clarify the differences. In addition, the objective was to reduce the burden on patients to formulate a treatment policy, take countermeasures, and reduce recurrent cases. |
| Basic objectives2 | Others |
| Basic objectives -Others | Vocal fold leukoplakia is a benign disease caused by hoarseness, caused by the thickening of the squamous epithelium. The causes include various stages from temporary hyperplasia associated with inflammation such as the common cold to dysplasia involving infiltration of atypical cells into the epithelium and cancer. It is known that even if hyperplasia is found in pathological diagnosis by tissue biopsy, malignant transformation occurs only by follow-up observation. Extensive resection for complete removal of lesions impairs speech function. In addition, the canceration of recurrent lesions is still being reported. If this study reduces the rate of recurrence of vocal fold leukoplakia, it can prevent cancer associated with the recurrence and reduce the psychological, physical, and economic burden on patients associated with treatment for the recurrence. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The postoperative recurrence rate of vocal fold leukoplakia |
| Key secondary outcomes | Gender, age, drinking history, smoking history, pathological diagnosis, pharyngolaryngeal reflux, unilateral or bilateral vocal cord lesions, lesion length relative to the total length of the vocal cords, postoperative follow-up period, presence or absence of inferior surface lesions, associative lesions Presence/absence of laryngeal expansion |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Those that meet all of the following criteria
Vocal cord leukoplakia Age: 20 years old or older, less than 90 years old Gender: both gender They were the first to undergo surgery for the above disease at Nihon University Hospital. Surgery involves both tissue sampling and resection of the lesion and Ho; YAG laser treatment |
|||
| Key exclusion criteria | Diagnosis of pathological carcinoma in situ and invasive carcinoma and those who have previous treatment | |||
| Target sample size | 39 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nihon University Hospital | ||||||
| Division name | Otorhinolaryngology and Head and Neck Surgery | ||||||
| Zip code | 101-8309 | ||||||
| Address | 1-6, Kandasurugadai | ||||||
| TEL | 0332931711 | ||||||
| hasegawa.hisashi@nihon-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nihon University Hospital | ||||||
| Division name | Otorhinolaryngology and Head and Neck Surgery | ||||||
| Zip code | 101-8309 | ||||||
| Address | 1-6, Kandasurugadai | ||||||
| TEL | 0332931711 | ||||||
| Homepage URL | |||||||
| hasegawa.hisashi@nihon-u.ac.jp | |||||||
| Sponsor | |
| Institute | Nihon University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nihon University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Otorhinolaryngology and Head and Neck Surgery |
| Address | 1-6, Kandasurugadai |
| Tel | 03-3293-1711 |
| hasegawa.hisashi@nihon-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 39 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | A retrospective review |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045002 |